Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (clinicaltrials.gov) - Oct 22, 2026 - P3 | N=156 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Oct 2029 ➔ Aug 2033 | Trial primary completion date: Oct 2026 ➔ Aug 2030
Trial completion date • Trial primary completion date • Bone Marrow Transplantation • CNS Disorders • Multiple Sclerosis • Transplantation
|